Breaking News
March 22, 2019 - Less invasive valve replacement can be safe and effective alternative for healthier patients
March 22, 2019 - Aphasia research reveals new, complex interactions between thought and language
March 22, 2019 - Artificial neural networks can predict how different areas in the brain respond to words
March 22, 2019 - Age-related changes to gut microbiome have adverse impact on vascular health, study shows
March 22, 2019 - Isolated seniors chat online to prevent cognitive decline
March 22, 2019 - Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
March 22, 2019 - Eruptive xanthomatosis
March 22, 2019 - Cause of vascular disease in kidney failure reversed in animal model
March 22, 2019 - Researchers discover possible new therapeutic strategy for pancreatic cancer
March 22, 2019 - Ebola spreads to second largest city in DRC
March 22, 2019 - Perivascular spaces contribute to worse cognitive health in older adults
March 22, 2019 - Adolescent daily users more likely to obtain electronic cigarettes from commercial sources
March 22, 2019 - FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
March 22, 2019 - Diabetes myths and facts: MedlinePlus Medical Encyclopedia
March 22, 2019 - TGen and ABL pursue global rollout of advanced TB test
March 22, 2019 - Traffic light labels influence people to choose healthier and more sustainable meals
March 22, 2019 - Alzheimer’s patients using antiepileptic drugs have twice the risk of pneumonia, study shows
March 22, 2019 - Skin diseases may be more prevalent than previously thought
March 22, 2019 - Overall rates of death from breast cancer are falling across the EU
March 22, 2019 - Novel plasmid could hold key to control of mosquito-borne illness
March 22, 2019 - Female Emergency Physicians Paid Less Than Males
March 22, 2019 - Estimated average glucose (eAG): MedlinePlus Medical Encyclopedia
March 22, 2019 - Experimental drug could be new option for type 2 diabetes
March 22, 2019 - Five Things To Know About The Electronic Health Records Mess
March 22, 2019 - TMJ disorders could be treated with tissue-engineered implants after successful animal study
March 22, 2019 - Team-based approach is key to successful care of pregnant women with heart failure
March 22, 2019 - Study identifies gene variant associated with accelerated cellular aging
March 21, 2019 - Salk scientists show how background noise from neurons can interrupt focused attention
March 21, 2019 - New class of drugs could help treat patients diagnosed with ovarian cancer
March 21, 2019 - Tecentriq Approved for Small Cell Lung Cancer
March 21, 2019 - Adipocyte glucocorticoid receptors play a role in developing steroid diabetes
March 21, 2019 - Climate change can affect nutrient content of crops, harming human health
March 21, 2019 - Podcast: KHN’s ‘What The Health’ Surprise! Fixing Surprise Medical Bills Is Harder Than it Looks
March 21, 2019 - Chemistry researchers patent new method for making anti-leukemia compounds
March 21, 2019 - UIC scientists identify hidden proteins in bacteria
March 21, 2019 - New Australian drug trial achieves remarkable results in patients with acute myeloid leukemia
March 21, 2019 - Females live longer when they have help raising offspring
March 21, 2019 - How did orthodontists sell orthodontics?
March 21, 2019 - In the Spotlight: From dietitian to physician assistant student
March 21, 2019 - The CRISPR Revolution: What You Need to Know
March 21, 2019 - FDA Chief Calls For Stricter Scrutiny Of Electronic Health Records
March 21, 2019 - Combined glucocorticoid and antioxidant therapy could benefit premature babies
March 21, 2019 - Low levels of certain eye proteins could serve as predictor for Alzheimer’s
March 21, 2019 - Post-traumatic holocaust survivors transmit negative views on aging to offspring
March 21, 2019 - City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma
March 21, 2019 - New video game-led training device helps stroke survivors regain arm mobility
March 21, 2019 - Compounds in coffee could slow prostate cancer growth
March 21, 2019 - New mobile DNA element in Wolbachia may contribute to improved disease control strategies
March 21, 2019 - Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics
March 21, 2019 - More than one-third of patients risk major bleeding by doubling up on blood thinners
March 21, 2019 - A skeptical look at popular diets: Thumbs up for Mediterranean
March 21, 2019 - PTSD After Cardiac Arrest Predicts More Heart Trouble
March 21, 2019 - Role of immunological imprinting in elicitation of new antibodies
March 21, 2019 - Breast cancer relapse predictor tool may soon be a reality
March 21, 2019 - New computer program developed by TGen lights up cancer-causing genetic mutations
March 21, 2019 - FDA warns two breast implant makers for failure to comply with post-approval study requirements
March 21, 2019 - Butler Hospital receives COBRE grant to enhance research on neuropsychiatric illnesses
March 21, 2019 - Majority of osteoporosis clinical practice guidelines ignore patients’ voices
March 21, 2019 - Generic messages don’t help patients to lose weight
March 21, 2019 - Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
March 21, 2019 - Two-drug combos using popular calcium channel blocker show superiority in lowering BP
March 21, 2019 - Q BioMed and Mannin Research collaborate with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit
March 21, 2019 - First-in-human pilot study shows positive results for ‘bacteria-phobic’ catheter
March 21, 2019 - Itamar Medical launches next-generation WatchPAT system for home sleep apnea testing
March 21, 2019 - Study estimates health and economic impacts of healthy food prescriptions
March 21, 2019 - Detecting fungal disease in crops with multispectral imaging system
March 21, 2019 - MIT announces creation of the Alana Down Syndrome Center
March 21, 2019 - Next-generation LVAD device clinically superior, safer for heart failure patients
March 21, 2019 - Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients
March 21, 2019 - Mutations in noncoding genes could play big role in regulating cancer, study finds
March 21, 2019 - A medical student’s thoughts on Match Day
March 21, 2019 - Are eggs good or bad for you?
March 21, 2019 - New analysis reveals precision oncology insights for colorectal cancer
March 21, 2019 - Pollutants appear to weaken immune system and increase pathogen virulence
March 21, 2019 - Researchers develop and validate scale for rating severity of mononucleosis
March 21, 2019 - Scientists identify generation of key immune response in mice on introducing solid food
March 21, 2019 - New nanomaterial could restore internal structure of damaged bones
March 21, 2019 - Selective destruction of prostate tumor as effective as complete prostate removal
March 21, 2019 - 2011 to 2015 Saw Increase in Psychiatric ED Visits for Youth
March 21, 2019 - Tapeworm drug targets common vulnerability in tumor cells
One type of Chlamydia protein manipulates human cells in two different ways

One type of Chlamydia protein manipulates human cells in two different ways

image_pdfDownload PDFimage_print

When Chlamydia trachomatis, the bacterium that causes one of the most common sexually transmitted infections worldwide, infects a human cell, it hijacks parts of the host to build protective layers around itself.

Inside this makeshift fortress, the bug grows and reproduces, eventually bursting out in search of a new target and killing the host cell. While scientists have known for years that Chlamydia protects itself in this way, they were missing the mechanics until now.

Researchers from Duke University and the MRC Laboratory of Molecular Biology in Cambridge, UK, have shown that one Chlamydia protein, known as ChlaDUB1, is capable of manipulating human cells in two different ways, at least one of which appears to be essential for thriving inside its host.

The findings which appeared this week in Nature Microbiology could pave the way for treating Chlamydia with fewer antibiotics.

Structural biologists led by David Komander of the MRC Laboratory of Molecular Biology and Chlamydia experts at Duke University collaborated on the study. Initially, Komander and postdoctoral fellow Jonathan Pruneda, now an assistant professor at Oregon Health & Science University, contacted Duke Professor Raphael Valdivia, Vice Dean for Basic Science, to discuss the ChlaDUB1 protein, which Valdivia’s team had worked on before.

ChlaDUB1 is one of a class of proteins generated by Chlamydia to disrupt host cell function. Komander, Pruneda, and colleagues found that the protein is an enzyme, a deubiquitinase, that removes ubiquitin, a small protein that human cells attach to other proteins to activate them or to indicate that those proteins should be torn up. Human cells use ubiquitin to send signals, many of which are important for inflammatory responses to pathogens like Chlamydia.

Komander’s group determined through further study of the ChlaDUB1 enzyme’s shape that it can also modify proteins with acetylation to disrupt the alarms human cells raise to fight infection.

“Instead of making two proteins, one that has the deubiquitinase activity and a separate one that has acetylation activity, they’ve combined that into the same protein,” said coauthor Robert Bastidas, a research assistant professor who is part of Valdivia’s group at Duke.

Chlamydia is unlike other bacteria in that it can’t survive on its own outside of a human cell, Bastidas explained. He said it is likely that the bug has cast off large parts of its genome in order to better survive inside host cells. He hypothesizes that the bacterium saves space with this mashed-together protein, the only Chlamydia protein that has been found to have these two functions.

While it was clear that ChlaDUB1 was capable of both functions, Bastidas and his colleagues at Duke wanted to know what the enzyme was doing inside its host during Chlamydia infection. The researchers infected human cells with wildtype Chlamydia, as well as with mutant strains harboring defective copies of ChlaDUB1.

Once Chlamydia has built its fortress within the host cell, it breaks up the host cell’s Golgi apparatus and maneuvers the pieces around itself. The Golgi apparatus is a cellular compartment that typically stays close to the nucleus of the cell and modifies proteins by adding sugars that serve as baggage tags indicating whether the proteins should go to the plasma membrane or to some other cellular compartment. It’s not clear why the bacterium surrounds itself with pieces of the Golgi, perhaps to use the sugars and fats for its own growth, but it’s the only bacterium known to do so.

In the scientists’ infection trials, the wildtype Chlamydia chopped up the Golgi as usual. But when infected with a bug carrying a mutant enzyme, the human cells’ Golgi remained intact, suggesting that ChlaDUB1’s activity is necessary for this aspect of Chlamydia infection.

Bastidas also hypothesizes that the ability for ChlaDUB1 to remove ubiquitin from host proteins protects Chlamydia from the host inflammatory response.

Next, the researchers want to find a drug that will specifically disrupt the function of ChlaDUB1, thus slowing the bacteria’s ability to fight off attack by the host immune system. “If we develop these inhibitors and they’re specific enough, then we won’t have to use antibiotics” or at least use fewer of them, said Bastidas.

In a world where antibiotic use can lead to antibiotic resistance or to disruption of the delicate microbiome of the vagina and the urinary tract, where Chlamydia prefers to reside, Bastidas says a more tailored therapy could prove a better tool to fight infection.

Tagged with:

About author

Related Articles